Focused research review
Is CBN good for sleep?
Small randomized studies reported improvements in some CBN sleep measures, including nighttime awakenings or subjective sleep disturbance. Other outcomes did not consistently differ from placebo, and the results are product-specific.
The short answer
What is the bottom line?
CBN has early human sleep evidence, including a small trial with no significant improvement in its primary wake-after-sleep-onset outcome. 1 2 3 4
Some studies reported fewer nighttime awakenings or lower overall sleep disturbance, while other outcomes such as sleep-onset latency, wake after sleep onset, or daytime fatigue did not differ from placebo. CBN-alone, CBN-plus-CBD, and branded formulations should remain separate. 1 2 3 4
What this means: CBN is worth studying further for sleep, but the current research does not support a simple claim that it works for every sleep problem. Read the endpoint, product, dose, comparison group, and next-day measures before drawing a conclusion. 1 2 3 4
How to read this answer: CBN is worth studying further for sleep, but the current research does not support a simple claim that it works for every sleep problem. Read the endpoint, product, dose, comparison group, and next-day measures before drawing a conclusion. It includes 14 specific study findings from 4 sources. 1
Key takeaways
What to know first
- 1
In one small CBN insomnia trial, the primary wake-after-sleep-onset outcome did not differ significantly from placebo. 1
- 2
A separate CBN study reported fewer nighttime awakenings and lower overall sleep disturbance, while sleep onset, wake after sleep onset, and daytime fatigue did not differ from placebo. 2
- 3
Rat sleep-architecture research is useful biological context, not proof of a human sleep effect. 3
Choose your question
What part of sleep do you care about?
Sleep quality, falling asleep, staying asleep, total sleep, and next-day function are different outcomes. Open the studies that measured the one you mean.
-
01Reader questionExplore the evidence
Staying asleep
Compare nighttime awakenings and wake-after-sleep-onset rather than treating them as the same measure.
-
02Reader questionExplore the evidence
Falling asleep
See the sleep-onset-latency results and why they do not match every other sleep outcome.
-
03Reader questionExplore the evidence
Sleep quality
Read the subjective sleep-quality and overall-disturbance findings alongside product details.
-
04Reader questionExplore the evidence
Next-day effects
Check daytime fatigue, reported adverse events, and the difference between nighttime and next-day measures.
Research areas
What researchers studied about CBN and sleep
These are the main questions represented in the current literature. Each link opens a source used to build the overview.
Too limited for a firm answer
Sleep
This part of the literature focuses on Sleep. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 5
Human research included
Overall sleep disturbance
This part of the literature focuses on Overall sleep disturbance. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 3
Human research included
Sleep onset latency
This part of the literature focuses on Sleep onset latency. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 1
Human research included
Wake after sleep onset
This part of the literature focuses on Wake after sleep onset. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 1
Human research included
Adverse events
This part of the literature focuses on Adverse events. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 1
Results extracted so far
What did the studies report?
These summaries appear only when the recorded study outcome is specific enough to reproduce from the linked source. If a source has no result summary here, the result has not been extracted yet; that does not mean the study found no effect.
-
In a randomized double-blind placebo-controlled crossover trial involving 20 adults with physician-diagnosed insomnia disorder, researchers did not detect a difference in wake after sleep onset following a single oral dose of 30 mg or 300 mg CBN. The recorded comparator was placebo. 1
-
In a randomized double-blind placebo-controlled crossover trial involving 20 adults with physician-diagnosed insomnia disorder, researchers reported shorter sleep onset latency following 300 mg CBN. The recorded comparator was placebo. 1
-
In a randomized double-blind placebo-controlled crossover trial involving 20 adults with physician-diagnosed insomnia disorder, researchers reported higher subjective sleep quality following 300 mg CBN. The recorded comparator was placebo. 1
-
In a randomized double-blind placebo-controlled crossover trial involving 20 adults with physician-diagnosed insomnia disorder, researchers reported more NREM-2 sleep following 300 mg CBN. The recorded comparator was placebo. 1
-
In a double-blind randomized placebo-controlled study involving adults 18-55 with poor self-rated sleep quality, researchers reported fewer nighttime awakenings following 20 mg CBN over 7 nights. The recorded comparator was placebo. 2
-
In a double-blind randomized placebo-controlled study involving adults 18-55 with poor self-rated sleep quality, researchers reported lower overall sleep disturbance following 20 mg CBN over 7 nights. The recorded comparator was placebo. 2
-
In a double-blind randomized placebo-controlled study involving adults 18-55 with poor self-rated sleep quality, researchers did not detect a difference in sleep onset latency following 20 mg CBN over 7 nights. The recorded comparator was placebo. 2
-
In a double-blind randomized placebo-controlled study involving adults 18-55 with poor self-rated sleep quality, researchers did not detect a difference in wake after sleep onset following 20 mg CBN over 7 nights. The recorded comparator was placebo. 2
-
In a double-blind randomized placebo-controlled study involving adults 18-55 with poor self-rated sleep quality, researchers did not detect a difference in daytime fatigue following 20 mg CBN over 7 nights. The recorded comparator was placebo. 2
-
In a decentralized randomized double-blind placebo-controlled trial, researchers reported lower overall sleep disturbance following 25 mg, 50 mg, or 100 mg oral CBN formulation. The recorded comparator was placebo and 4 mg melatonin. 3
-
In a decentralized randomized double-blind placebo-controlled trial, researchers did not detect a difference in side effect frequency following 25 mg, 50 mg, or 100 mg oral CBN formulation. The recorded comparator was placebo. 3
-
In a rat polysomnography study, researchers reported more total sleep time. This does not establish the same result in people. 4
-
In a rat polysomnography study, researchers reported more NREM sleep. This does not establish the same result in people. 4
-
In a rat polysomnography study, researchers reported more REM sleep. This does not establish the same result in people. 4
How strong is the research?
Not every study answers the same question
This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.
Human studies
Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.
Reviews and evidence summaries
Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.
Lab, animal, and mechanism research
Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.
Another 1 of 10 research source could not be placed cleanly into those three groups from the recorded study details.
What these studies actually looked at
The research on CBN and sleep is not one kind of study. This source set includes 5 clinical studies in people, 3 narrative or expert reviews, 1 mechanism-focused study, and 1 rat polysomnography study. 3
The recorded populations or models include people or patients (5 sources), 20 adults with physician-diagnosed insomnia disorder (1 source), and adults 18-55 with poor self-rated sleep quality (1 source). A result from one group or model should not be assumed to apply to another. 4
The most common recorded outcome focus is sleep-related outcomes (5 sources), sleep onset latency (2 sources), and daytime fatigue (1 source). Closely related outcome names can still describe different measurements. 5
Some source records specify doses including 20 mg CBN (1 source), 25 mg, 50 mg, or 100 mg oral CBN formulation (1 source), and 300 mg CBN (1 source). These are descriptions of what researchers tested, not personal dosing instructions. 6
The CBN and sleep source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 7
Examples from the literature
What did the studies actually look at?
Each example names the research question and the study details recorded for that source.
clinical study in people
Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial
On this page, this source examines CBN and wake after sleep onset, CBN and sleep onset latency, and CBN and subjective sleep quality and other related questions. 1
- Study type
- clinical study in people
- Population or model
- 20 adults with physician-diagnosed insomnia disorder
- Outcome focus
- polysomnography wake after sleep onset and sleep onset latency and other recorded details
- Dose recorded
- single oral dose of 30 mg or 300 mg CBN and 300 mg CBN and other recorded details
- Evidence stage
- human research
clinical study in people
A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality
On this page, this source examines CBN and nighttime awakenings, CBN and sleep onset latency, wake after sleep onset, or daytime fatigue, and CBN and overall sleep disturbance and other related questions. 2
- Study type
- clinical study in people
- Population or model
- adults 18-55 with poor self-rated sleep quality
- Outcome focus
- number of awakenings and sleep onset latency, wake after sleep onset, or daytime fatigue and other recorded details
- Dose recorded
- 20 mg CBN
- Evidence stage
- human research
clinical study in people
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Effectiveness and Safety of Melatonin and Three Formulations of Floraworks Proprietary TruCBN for Improving Sleep
On this page, this source examines CBN and overall sleep disturbance and CBN and side effect frequency. 3
- Study type
- clinical study in people
- Population or model
- people or patients
- Outcome focus
- pROMIS Sleep Disturbance 8A and side effect frequency
- Dose recorded
- 25 mg, 50 mg, or 100 mg oral CBN formulation
- Evidence stage
- human research
rat polysomnography study
A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats
On this page, this source examines CBN and total sleep time, CBN and nREM sleep, and CBN and rEM sleep and other related questions. 4
- Study type
- rat polysomnography study and mechanism-focused study
- Population or model
- rats
- Outcome focus
- total sleep time and nREM sleep and other recorded details
- Evidence stage
- preclinical research and mechanism-focused research
narrative or expert review
Using Cannabis and CBD to Sleep: An Updated Review.
On this page, this source examines CBN and sleep. 5
- Study type
- narrative or expert review
- Population or model
- people or patients
- Outcome focus
- sleep-related outcomes
- Evidence stage
- evidence still limited
Safety and limits
What should readers keep in mind?
Research on CBN and sleep should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 1
Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.
Common questions
Questions people ask
Is CBN good for sleep?
CBN has early human sleep evidence, but the findings are mixed and specific to the tested product and endpoint. Some studies reported fewer nighttime awakenings or lower sleep disturbance, while other sleep outcomes did not differ from placebo. 7
Does CBN help you stay asleep?
One small randomized study reported fewer nighttime awakenings with 20 mg CBN, but the overall human evidence remains limited and needs replication. 8
Does CBN help you fall asleep faster?
The approved CBN study set does not show a consistent placebo-controlled effect on sleep-onset latency. Sleep onset and nighttime awakenings are separate outcomes. 9
Does CBN improve sleep quality?
Some study results suggest lower overall sleep disturbance or changes in subjective sleep measures. The studies used different CBN products and endpoints, so there is no single established answer. 10
Is CBN with CBD the same as CBN alone?
No. Combination products test a different formulation question and cannot isolate a CBN-only effect. 1
Sources
Read the research
The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.
-
1
Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial clinical study in people; human research PubMed 41698831 DOI 10.1111/jsr.70284
-
2
A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality clinical study in people; human research PubMed 37796540 DOI 10.1037/pha0000682
-
3
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Effectiveness and Safety of Melatonin and Three Formulations of Floraworks Proprietary TruCBN for Improving Sleep clinical study in people; human research PubMed 39204082 DOI 10.3390/ph17080977
-
4
A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats rat polysomnography study; mechanism-focused study; preclinical research; mechanism-focused research PubMed 39528623 DOI 10.1038/s41386-024-02018-7
-
5
Using Cannabis and CBD to Sleep: An Updated Review. narrative or expert review; evidence still limited PubMed 39612156 DOI 10.1007/s11920-024-01564-7
-
6
Medical cannabis for treatment of insomnia in adults: A systematic review and meta-analysis. human research PubMed 42207928 DOI 10.1097/jxx.0000000000001289
-
7
Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. clinical study in people; evidence still limited PubMed 37612115 DOI 10.1136/bmjopen-2022-071148
-
8
Effectiveness of a Cannabinoids Supplement on Sleep and Mood in Adults With Subthreshold Insomnia: A Randomized Double-Blind Placebo-Controlled Crossover Pilot Trial. clinical study in people; human research PubMed 39980821 DOI 10.1002/hsr2.70481
-
9
Cannabinoids, Insomnia, and Other Sleep Disorders. narrative or expert review; evidence still limited PubMed 35537535 DOI 10.1016/j.chest.2022.04.151
-
10
Cannabinol and Sleep: Separating Fact from Fiction narrative or expert review; evidence still limited PubMed 34468204 DOI 10.1089/can.2021.0006
See all 10 research sources
This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.
- Cannabinol and Sleep: Separating Fact from Fiction narrative or expert review; evidence still limited / 1 linked research note PubMed 34468204
- A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality clinical study in people; human research / 6 linked research notes PubMed 37796540
- A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Effectiveness and Safety of Melatonin and Three Formulations of Floraworks Proprietary TruCBN for Improving Sleep clinical study in people; human research / 2 linked research notes PubMed 39204082
- Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial clinical study in people; human research / 5 linked research notes PubMed 41698831
- A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats rat polysomnography study; mechanism-focused study; preclinical research; mechanism-focused research / 4 linked research notes PubMed 39528623
- Using Cannabis and CBD to Sleep: An Updated Review. narrative or expert review; evidence still limited / 1 linked research note PubMed 39612156
- Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. clinical study in people; evidence still limited / 1 linked research note PubMed 37612115
- Cannabinoids, Insomnia, and Other Sleep Disorders. narrative or expert review; evidence still limited / 1 linked research note PubMed 35537535
- Medical cannabis for treatment of insomnia in adults: A systematic review and meta-analysis. human research / 1 linked research note PubMed 42207928
- Effectiveness of a Cannabinoids Supplement on Sleep and Mood in Adults With Subthreshold Insomnia: A Randomized Double-Blind Placebo-Controlled Crossover Pilot Trial. clinical study in people; human research / 1 linked research note PubMed 39980821